The Multicenter Myocarditis Specific BioBank

Throughout most of the history of medical research, scientists were forced to acquire samples individually and, for the most part, work in relative isolation. This slowed the pace of medical discovery, especially in the case of rare diseases, where researchers had limited opportunities to collect samples and data.

For many common diseases, BioBanks were created to help accelerate discovery of new and valuable prognostic and diagnostic tests. These repositories of biological materials and information made it possible to collect and share a large number of specimens in a widely accessible database. There, scientists around the world can access the tissue samples and data they need and share their findings with the scientific community.

The Myocarditis Foundation began developing the first myocarditis specific sample focused BioBank in 2016. Since then, we’ve worked tirelessly to collaborate with researchers to create a diverse database of adult and pediatric myocarditis samples. The BioBank offers the fastest, most direct way to study the disease, offering hope for new blood tests to individuals affected by this often-devastating condition.

For Adult Myocarditis Samples, we will initially be working with 6 major institutions in the US who will be supplying the Biobank with diverse adult myocarditis patient blood samples.

For the Pediatric Myocarditis Samples, we will initially be working with 4 major pediatric institutions on obtaining diverse pediatric myocarditis blood samples.